Sinco Pharmaceuticals Holdings Limited
HKEX:6833.HK
0.184 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q2 | 2014 Q4 | 2014 Q2 | 2013 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,526.851 | 1,449.937 | 1,090.126 | 1,141.579 | 1,129.926 | 1,177.011 | 847.044 | 1,413.497 | 636.306 | 640.968 | 535.441 | 379.063 | 573.894 | 392.355 | 414.368 | 289.521 | 569.373 | 487.39 | 608.681 | 535.249 | 414.83 | 237.52 |
Cost of Revenue
| 1,353.639 | 1,279.203 | 937.58 | 1,027.909 | 937.728 | 969.588 | 689.517 | 1,248.25 | 527.727 | 512.048 | 444.514 | 385.546 | 464.261 | 350.151 | 388.252 | 268.007 | 486.319 | 417.588 | 525.976 | 468.315 | 351.994 | 205.077 |
Gross Profit
| 173.212 | 170.734 | 152.546 | 113.67 | 192.198 | 207.423 | 157.527 | 165.247 | 108.579 | 128.92 | 90.927 | -6.483 | 109.633 | 42.204 | 26.116 | 21.514 | 83.054 | 69.802 | 82.705 | 66.934 | 62.836 | 32.443 |
Gross Profit Ratio
| 0.113 | 0.118 | 0.14 | 0.1 | 0.17 | 0.176 | 0.186 | 0.117 | 0.171 | 0.201 | 0.17 | -0.017 | 0.191 | 0.108 | 0.063 | 0.074 | 0.146 | 0.143 | 0.136 | 0.125 | 0.151 | 0.137 |
Reseach & Development Expenses
| 13.4 | 6.791 | 1.5 | 11.27 | 0 | 26.16 | 0 | 0.369 | 0.443 | 1.198 | 0.387 | 1.397 | 0.677 | 0.898 | 1.098 | 2.746 | 2.343 | 1.831 | 1.197 | 0.821 | 0.904 | 0 |
General & Administrative Expenses
| 61.187 | 65.43 | 42.517 | 43.257 | 37.328 | 47.575 | 17.426 | 19.974 | 20.145 | 24.17 | 21.008 | 28.307 | 27.19 | 28.136 | 29.12 | 27.243 | 35.176 | 26.819 | 13.705 | 10.453 | 7.067 | 4.38 |
Selling & Marketing Expenses
| 36.468 | 46.612 | 47.101 | 49.249 | 67.767 | 70.501 | 34.874 | 28.507 | 61.329 | 70.067 | 44.469 | 150.275 | 118.301 | 84.805 | 11.114 | 9.41 | 2.06 | 3.124 | 2.585 | 3.998 | 2.794 | 1.698 |
SG&A
| 101.887 | 114.146 | 92.674 | 93.398 | 111.246 | 120.55 | 51.846 | 50.383 | 79.655 | 90.566 | 71.101 | 179.533 | 145.491 | 112.941 | 40.234 | 36.653 | 37.236 | 29.943 | 16.29 | 14.451 | 9.861 | 6.078 |
Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.109 | -0.223 | -0.223 |
Operating Expenses
| 115.287 | 120.937 | 106.15 | 90.45 | 104.735 | 123.369 | 54.062 | 55.195 | 77.76 | 98.17 | 59.007 | 200.215 | 140.759 | 177.389 | 55.277 | 33.181 | 39.099 | 38.132 | 21.022 | 17.773 | 13.361 | 5.855 |
Operating Income
| 57.925 | 49.797 | 56.272 | 20.272 | 80.952 | 86.873 | 105.681 | 114.864 | 28.924 | 38.856 | 19.324 | -180.042 | -36.969 | -70.737 | -14.118 | -15.139 | 45.818 | 39.859 | 66.415 | 52.483 | 52.975 | 22.319 |
Operating Income Ratio
| 0.038 | 0.034 | 0.052 | 0.018 | 0.072 | 0.074 | 0.125 | 0.081 | 0.045 | 0.061 | 0.036 | -0.475 | -0.064 | -0.18 | -0.034 | -0.052 | 0.08 | 0.082 | 0.109 | 0.098 | 0.128 | 0.094 |
Total Other Income Expenses Net
| 10.069 | 7.315 | -13.503 | 0.452 | -2.384 | -11.17 | -13.997 | -9.075 | 1.242 | -17.691 | 2.466 | -40.6 | -14.404 | -88.414 | -21.599 | 0.289 | -5.402 | -11.063 | -8.573 | -5.476 | -6.17 | 1.134 |
Income Before Tax
| 67.994 | 57.112 | 42.769 | 20.724 | 78.568 | 75.703 | 91.684 | 105.789 | 30.166 | 21.165 | 21.79 | -220.642 | -51.373 | -159.151 | -35.717 | -14.85 | 40.416 | 28.796 | 57.842 | 47.007 | 46.805 | 23.453 |
Income Before Tax Ratio
| 0.045 | 0.039 | 0.039 | 0.018 | 0.07 | 0.064 | 0.108 | 0.075 | 0.047 | 0.033 | 0.041 | -0.582 | -0.09 | -0.406 | -0.086 | -0.051 | 0.071 | 0.059 | 0.095 | 0.088 | 0.113 | 0.099 |
Income Tax Expense
| 44.124 | 34.355 | 23.174 | 13.185 | 16.645 | 15.901 | 16.403 | 20.104 | 2.286 | 12.821 | 6.584 | 11.236 | 2.636 | 4.775 | 4.196 | 2.641 | 9.87 | 8.054 | 9.143 | 6.244 | 7.439 | 3.421 |
Net Income
| 23.87 | 22.757 | 19.595 | 7.539 | 61.923 | 59.802 | 75.281 | 85.685 | 32.452 | 8.345 | 15.207 | -231.878 | -48.736 | -154.376 | -31.52 | -11.695 | 31.062 | 20.915 | 48.699 | 35.171 | 34.196 | 20.032 |
Net Income Ratio
| 0.016 | 0.016 | 0.018 | 0.007 | 0.055 | 0.051 | 0.089 | 0.061 | 0.051 | 0.013 | 0.028 | -0.612 | -0.085 | -0.393 | -0.076 | -0.04 | 0.055 | 0.043 | 0.08 | 0.066 | 0.082 | 0.084 |
EPS
| 0.012 | 0.011 | 0.01 | 0.004 | 0.031 | 0.034 | 0.045 | 0.051 | 0.019 | 0.005 | 0.009 | -0.14 | -0.029 | -0.096 | -0.02 | -0.007 | 0.021 | 0.017 | 0.041 | 0.029 | 0.029 | 0.017 |
EPS Diluted
| 0.012 | 0.011 | 0.01 | 0.004 | 0.031 | 0.034 | 0.045 | 0.051 | 0.019 | 0.005 | 0.009 | -0.14 | -0.029 | -0.096 | -0.02 | -0.007 | 0.021 | 0.017 | 0.041 | 0.029 | 0.029 | 0.017 |
EBITDA
| 78.611 | 65.98 | 61.362 | 24.686 | 84.325 | 89.546 | 108.145 | 118.4 | 33.646 | 43.475 | 24.032 | -174.943 | -31.705 | -63.011 | -6.595 | -9.771 | 51.048 | 45.051 | 71.452 | 53.692 | 53.644 | 22.789 |
EBITDA Ratio
| 0.051 | 0.046 | 0.056 | 0.022 | 0.075 | 0.076 | 0.128 | 0.084 | 0.053 | 0.068 | 0.045 | -0.462 | -0.055 | -0.161 | -0.016 | -0.034 | 0.09 | 0.092 | 0.117 | 0.1 | 0.129 | 0.096 |